TRENDSPOTTER: Revolving IPO Door, Consolidation, and Some Cash Await Genomics Sector in 2002 | GenomeWeb

Being the last TrendSpotter column of the year gives me the privilege of looking back on how our industry fared in 2001—not universally a pleasant task. It also gives me the opportunity to look at the road ahead, which also may be perilous in certain places.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.